Denkert, Carsten <br/><br/>
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.  [electronic resource] 

 -  Lancet (London, England)  Jun 2017 
 - 2430-2442 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(16)32454-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>BRCA2 Protein--genetics<br/>Biomarkers, Tumor--metabolism<br/>Female<br/>Gene Expression Profiling--methods<br/>Genomics--methods<br/>Humans<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Molecular Targeted Therapy--methods<br/>Mutation<br/>Neoadjuvant Therapy--methods<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Ubiquitin-Protein Ligases--genetics